Alcon Operating Income 2019-2025 | ALC
Alcon annual/quarterly operating income history and growth rate from 2019 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
- Alcon operating income for the quarter ending June 30, 2025 was $247M, a 22.33% decline year-over-year.
- Alcon operating income for the twelve months ending June 30, 2025 was $1.442B, a 21.48% increase year-over-year.
- Alcon annual operating income for 2024 was $1.413B, a 36% increase from 2023.
- Alcon annual operating income for 2023 was $1.039B, a 54.61% increase from 2022.
- Alcon annual operating income for 2022 was $0.672B, a 15.86% increase from 2021.
| Alcon Annual Operating Income (Millions of US $) |
|
|---|---|
| 2024 | $1,413 |
| 2023 | $1,039 |
| 2022 | $672 |
| 2021 | $580 |
| 2020 | $-482 |
| 2019 | $-187 |
| 2018 | $-248 |
| Alcon Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2025-06-30 | $247 |
| 2025-03-31 | $468 |
| 2024-12-31 | $395 |
| 2024-09-30 | $332 |
| 2024-06-30 | $318 |
| 2024-03-31 | $368 |
| 2023-12-31 | $208 |
| 2023-09-30 | $293 |
| 2023-06-30 | $270 |
| 2023-03-31 | $268 |
| 2022-12-31 | $21 |
| 2022-09-30 | $205 |
| 2022-06-30 | $200 |
| 2022-03-31 | $246 |
| 2021-12-31 | $182 |
| 2021-09-30 | $20 |
| 2021-06-30 | $229 |
| 2021-03-31 | $149 |
| 2020-12-31 | $141 |
| 2020-09-30 | $-129 |
| 2020-06-30 | $-466 |
| 2020-03-31 | $-28 |
| 2019-12-31 | $-68 |
| 2019-09-30 | $-18 |
| 2019-06-30 | $-53 |
| 2019-03-31 | $-48 |
| 2018-12-31 | |
| 2018-09-30 | $-284 |
| 2018-06-30 | $38 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $39.973B | $9.911B |
| Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $186.846B | 22.60 |
| Intuitive Surgical (ISRG) | United States | $172.230B | 71.39 |
| IDEXX Laboratories (IDXX) | United States | $51.191B | 53.28 |
| Edwards Lifesciences (EW) | United States | $47.784B | 31.67 |
| IQVIA Holdings (IQV) | United States | $32.647B | 18.45 |
| DexCom (DXCM) | United States | $32.027B | 48.04 |
| Mettler-Toledo (MTD) | United States | $27.126B | 32.20 |
| STERIS (STE) | Ireland | $24.578B | 26.16 |
| Waters (WAT) | United States | $17.663B | 24.26 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.277B | 0.00 |
| Hologic (HOLX) | United States | $15.294B | 16.57 |
| Penumbra (PEN) | United States | $9.973B | 72.86 |
| Sysmex ADR (SSMXY) | Japan | $8.372B | 26.60 |
| Globus Medical (GMED) | United States | $8.202B | 18.92 |
| Masimo (MASI) | United States | $7.912B | 26.63 |
| Teleflex (TFX) | United States | $5.553B | 8.96 |
| Glaukos (GKOS) | United States | $5.215B | 0.00 |
| TransMedics (TMDX) | United States | $4.155B | 63.15 |
| Integer Holdings (ITGR) | United States | $3.759B | 18.76 |
| LivaNova (LIVN) | United Kingdom | $2.915B | 16.68 |
| Alphatec Holdings (ATEC) | United States | $2.351B | 0.00 |
| Veracyte (VCYT) | United States | $2.320B | 32.05 |
| PROCEPT BioRobotics (PRCT) | United States | $2.191B | 0.00 |
| Artivion (AORT) | United States | $2.030B | 102.43 |
| Nihon Kohden (NHNKY) | Japan | $1.894B | 22.61 |
| Elekta AB (EKTAY) | Sweden | $1.854B | 17.34 |
| Integra LifeSciences Holdings (IART) | United States | $1.111B | 6.37 |
| OPKO Health (OPK) | United States | $1.103B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.073B | 0.00 |
| IRadimed (IRMD) | United States | $0.888B | 43.10 |
| Tandem Diabetes Care (TNDM) | United States | $0.722B | 0.00 |
| AxoGen (AXGN) | United States | $0.716B | 0.00 |
| SiBone (SIBN) | United States | $0.670B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.665B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.574B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.527B | 9.31 |
| OrthoPediatrics (KIDS) | United States | $0.488B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.462B | 3.71 |
| Treace Medical Concepts (TMCI) | United States | $0.451B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.381B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.379B | 9.63 |
| AngioDynamics (ANGO) | United States | $0.371B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.361B | 86.08 |
| RxSight (RXST) | United States | $0.346B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.295B | 0.00 |
| NeuroPace (NPCE) | United States | $0.286B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.286B | 19.72 |
| Alpha Tau Medical (DRTS) | Israel | $0.260B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.234B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.223B | 0.00 |
| Neuronetics (STIM) | United States | $0.220B | 0.00 |
| 908 Devices (MASS) | United States | $0.214B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.213B | 0.00 |
| Inogen (INGN) | United States | $0.199B | 0.00 |
| CVRx (CVRX) | United States | $0.188B | 0.00 |
| Accuray (ARAY) | United States | $0.170B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.151B | 0.00 |
| LENSAR (LNSR) | United States | $0.150B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.148B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.128B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.112B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.109B | 0.00 |
| InspireMD (NSPR) | United States | $0.102B | 0.00 |
| Hyperfine (HYPR) | United States | $0.100B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.095B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.073B | 0.00 | |
| QT Imaging Holdings (QTIH) | United States | $0.063B | 0.00 |
| Positron (POSC) | United States | $0.059B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.058B | 23.33 |
| Sensus Healthcare (SRTS) | United States | $0.053B | 0.00 |
| Spectral AI (MDAI) | United States | $0.052B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.051B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.045B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.035B | 0.00 |
| Envoy Medical (COCH) | United States | $0.027B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.023B | 0.00 |
| DarioHealth (DRIO) | United States | $0.020B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.019B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Tenon Medical (TNON) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.009B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| Vyome Holdings (HIND) | United States | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.33 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |